At the “The 2nd Japan Open Innovation Prize” sponsored by the Cabinet Office, the theme “Producing blood in factories- Aiming to commercialize regenerative medicine using iPS cells” which was presented by five companies including us have won the “Minister of State for Science and Technology Policy Award”.

Press release is here.